Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID‐19: A case report

Despite its rarity, AIHA can be associated with COVID‐19. It should be suspected in a patient with recent COVID‐19 presenting with unexplained anemia.

• Publication year

  2021

• Venue

  Clinical Case Reports

• Publication date

  2021-10-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ccr3.4952PMID 34703600PMCID 8521316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombotic Complications in Patients with Immune-Mediated Hemolysis

  2021cited by this paper
• Coronavirus-induced autoimmunity

  2021cited by this paper
• Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

  2021cited by this paper
• A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative?

  2021cited by this paper
• Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids

  2021cited by this paper
• Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID‐19: A case report

  2021cited by this paper
• Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection

  2021cited by this paper
• Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis

  2021cited by this paper
• Autoimmune hemolytic anemia: current knowledge and perspectives

  2020cited by this paper
• Autoimmune haemolytic anaemia associated with COVID‐19 infection

  2020cited by this paper
• Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID‐19?

  2020cited by this paper
• Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study

  2020cited by this paper
• Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study

  2020cited by this paper
• Current and emerging treatment options for autoimmune hemolytic anemia

  2018cited by this paper
• Autoimmune hemolytic anemia.

  2015cited by this paper
• Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

  2015cited by this paper
• Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases

  2014cited by this paper
• Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review.

  2009cited by this paper

• Impact of Remdesivir Treatment on Factor VIII Gene Expression and Hematological Parameters in COVID-19 Patients.

  2025cites this paper
• Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes.

  2025cites this paper
• Hematological alterations associated with long COVID-19

  2023cites this paper
• Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID‐19: A case report

  2021cites this paper